Watch IRWD. Know when insiders buy.
One email the day a filing lands. Free.
IRWD
IRONWOOD PHARMACEUTICALS INC
4.23
+0.06 +1.44%
USD · close Sep 17
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
56
WATCH · shorts 56
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $699MP/E 5.5DIV YIELD —FCF YIELD —REV TTM $389.3M +26.2%NET INCOME $129.9MNET DEBT $120.4M52W 1.27 – 5.39SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $113M | +32.6% | — | $79.3M | $51.3M | +117.3% | 0.31 | $58.3M | — | — | Aug 6 |
| Q1 2026 · Mar 31 | $106.5M | +158.9% | — | $72.6M | $40.8M | — | 0.24 | $5.1M | — | — | May 7 |
| Q4 2025 · Dec 31 | $47.7M | −47.3% | — | $6.8M | −$2.3M | −200.9% | -0.01 | $74.6M | −$1K | $74.6M | Feb 26 |
| Q3 2025 · Sep 30 | $122.1M | +33.3% | — | $75.5M | $40.1M | +999.3% | 0.23 | $47.6M | $2K | $47.6M | Feb 26 |
| Q2 2025 · Jun 30 | $85.2M | −9.7% | — | $45.3M | $23.6M | — | 0.14 | −$15.1M | $2K | −$15.1M | Aug 6 |
| Q1 2025 · Mar 31 | $41.1M | −45.1% | — | −$29.1M | −$37.4M | — | -0.23 | $20M | $31K | $19.9M | May 7 |
| Q4 2024 · Dec 31 | $90.5M | −23.0% | — | $31.5M | $2.3M | — | 0.01 | $15.2M | $0 | $15.2M | Feb 26 |
| Q3 2024 · Sep 30 | $91.6M | −19.5% | — | $25.6M | $3.6M | −76.2% | 0.02 | $9.9M | $16K | $9.9M | Feb 26 |
| Q2 2024 · Jun 30 | $94.4M | — | — | $25M | −$860K | — | -0.01 | $33.5M | $58K | $33.4M | Feb 26 |
| Q1 2024 · Mar 31 | $74.9M | — | — | $11M | −$4.2M | — | -0.03 | $45M | $68K | $44.9M | Feb 26 |
| Q4 2023 · Dec 31 | $117.6M | — | — | $37.6M | −$1.1M | — | -0.01 | $35.8M | $211K | $35.6M | Mar 31 |
| Q3 2023 · Sep 30 | $113.7M | — | — | $40M | $15.3M | — | 0.09 | $32.5M | $49K | $32.4M | Mar 31 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $296.2M | — | $98.5M | $24M | 8.1% | 0.15 | $127M | $34K | $127M | — | — |
| FY2024 · to Dec 31 | $351.4M | — | $93.1M | $880K | 0.3% | 0.01 | $103.5M | $142K | $103.4M | — | — |
| FY2023 · to Dec 31 | $442.7M | — | −$945.4M | −$1B | -226.4% | -6.45 | $183.4M | $273K | $183.2M | — | — |
| FY2022 · to Dec 31 | $410.6M | — | $250.3M | $175.1M | 42.6% | 0.96 | $273.8M | $136K | $273.6M | $126.4M | — |
| FY2021 · to Dec 31 | $413.8M | — | $232.3M | $528.4M | 127.7% | 3.21 | $261.9M | $265K | $261.6M | $24.1M | — |
| FY2020 · to Dec 31 | $389.5M | 99.2% | $142.9M | $106.2M | 27.3% | 0.66 | $168.8M | $1.8M | $167M | — | — |
Every number comes from IRONWOOD PHARMACEUTICALS INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.